Published in AIDS Res Hum Retroviruses on September 01, 1998
Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease. J Virol (2002) 0.97
Rhesus macaques infected with macrophage-tropic simian immunodeficiency virus (SIVmacR71/17E) exhibit extensive focal segmental and global glomerulosclerosis. J Virol (1998) 0.90
Clinical monitoring and correlates of nephropathy in SIV-infected macaques during high-dose antiretroviral therapy. AIDS Res Ther (2011) 0.79
Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci U S A (1985) 4.66
Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. Science (1985) 4.31
Imaging membrane protein helical wheels. J Magn Reson (2000) 3.80
Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol (1986) 3.45
Antigenic shift of visna virus in persistently infected sheep. Science (1977) 3.17
Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med (1972) 3.09
Surface expression of viral glycoproteins is polarized in epithelial cells infected with recombinant vaccinia viral vectors. EMBO J (1986) 3.00
Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. J Gen Virol (1982) 2.87
Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J Virol (1996) 2.86
Selection of a fixative for identifying T cell subsets, B cells, and macrophages in paraffin-embedded mouse spleen. J Immunol Methods (1983) 2.82
Force fluctuations in bead packs. Science (1995) 2.59
Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect Immun (1983) 2.52
Lentiviral diseases of sheep and goats: chronic pneumonia leukoencephalomyelitis and arthritis. Rev Infect Dis (1985) 2.51
Genome comparisons reveal a dominant mechanism of chromosome number reduction in grasses and accelerated genome evolution in Triticeae. Proc Natl Acad Sci U S A (2009) 2.32
Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques. J Virol (1992) 2.30
Behavioral disease in rats caused by immunopathological responses to persistent borna virus in the brain. Science (1983) 2.10
Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein. Virology (1993) 2.09
Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol (2000) 2.08
Genomic changes associated with antigenic variation of visna virus durig persistent infection. Proc Natl Acad Sci U S A (1980) 2.04
Injecting drug use and HIV infection in southwest China. AIDS (1994) 1.91
Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus. N Engl J Med (1973) 1.90
Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques. Virology (1993) 1.89
Studies of the antigenic relationships of the new human papovaviruses by electron microscopy agglutination. Infect Immun (1973) 1.84
Antigenic variation in visna virus. Cell (1979) 1.81
Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. Dev Genet (1999) 1.80
Virus mutation during 'slow infection': temporal development and characterization of mutants of visna virus recovered from sheep. J Gen Virol (1978) 1.80
Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein. J Biol Chem (1994) 1.79
Slow virus infection: replication and mechanisms of persistence of visna virus in sheep. J Infect Dis (1977) 1.78
cis- and trans-acting transcriptional regulation of visna virus. Science (1985) 1.74
Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden. Virology (1994) 1.73
Genomic and phenotypic analyses of Mycoplasma pneumoniae strains. Infect Immun (1982) 1.72
The pathogenesis of viral leukoencephalomyelitis-arthritis of goats. I. Persistent viral infection with progressive pathologic changes. Lab Invest (1980) 1.72
The nucleic acid of an SV40-like virus isolated from a patient with progressive multifocal leukoencephalopathy. Virology (1973) 1.71
Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol (2000) 1.71
Pathogenesis of human poliovirus infection in mice. I. Clinical and pathological studies. J Neuropathol Exp Neurol (1980) 1.68
Pathogenesis of Borna disease in rats: immune-mediated viral ophthalmoencephalopathy causing blindness and behavioral abnormalities. J Infect Dis (1983) 1.66
A borna virus cDNA encoding a protein recognized by antibodies in humans with behavioral diseases. Science (1990) 1.63
A double labeling technique for performing immunocytochemistry and in situ hybridization in virus infected cell cultures and tissues. J Virol Methods (1985) 1.60
Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J Biol Chem (1995) 1.58
A new influenza A virus infection in turkeys II. A highly pathogenic variant, a/turkey/ontario 772/66. Can Vet J (1968) 1.54
Pathogenesis of Borna disease in rats: evidence that intra-axonal spread is the major route for virus dissemination and the determinant for disease incubation. J Virol (1987) 1.53
Biological characterization of the virus causing leukoencephalitis and arthritis in goats. J Gen Virol (1980) 1.53
Age dependence of viral expression: comparative pathogenesis of two rodent-adapted strains of measles virus in mice. Infect Immun (1974) 1.51
HIV-1 subtype C in China. Lancet (1995) 1.48
Efficiency of in situ hybridization as a function of probe size and fixation technique. J Virol Methods (1985) 1.47
Restricted replication of lentiviruses. Visna viruses induce a unique interferon during interaction between lymphocytes and infected macrophages. J Exp Med (1985) 1.46
Neutralizing antibodies to visna lentivirus: mechanism of action and possible role in virus persistence. J Virol (1986) 1.45
Virus-induced abortion. Studies of equine herpesvirus 1 (abortion virus) in hamsters. Lab Invest (1975) 1.45
Papovavirus of JC type in progressive multifocal leukoencephalopathy. Rapid identification and subsequent isolation. Arch Neurol (1973) 1.43
Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses. J Virol (1999) 1.43
HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors. Proc Natl Acad Sci U S A (1998) 1.42
Persistent expression of Ia antigen and viral genome in visna-maedi virus-induced inflammatory cells. Possible role of lentivirus-induced interferon. J Exp Med (1985) 1.39
Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections. J Virol (1998) 1.38
Genomic organization of the structural proteins of borna disease virus revealed by a cDNA clone encoding the 38-kDa protein. Virology (1993) 1.37
Polarized expression of a chimeric protein in which the transmembrane and cytoplasmic domains of the influenza virus hemagglutinin have been replaced by those of the vesicular stomatitis virus G protein. Proc Natl Acad Sci U S A (1986) 1.37
Early immune responses in visna, a slow viral disease of sheep. J Infect Dis (1978) 1.37
Pathogenesis of human poliovirus infection in mice. II. Age-dependency of paralysis. J Neuropathol Exp Neurol (1980) 1.37
Slow virus-macrophage interactions. Characterization of a transformed cell line of sheep alveolar macrophages that express a marker for susceptibility to ovine-caprine lentivirus infections. Lab Invest (1984) 1.37
Antigenic variation of SIV: mutations in V4 alter the neutralization profile. Virology (1996) 1.35
Ovine lentivirus is macrophagetropic and does not replicate productively in T lymphocytes. J Virol (1992) 1.35
Virions from progressive multifocal leukoencephalopathy: rapid serological identification by electron microscopy. Science (1972) 1.33
Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts. J Clin Invest (1997) 1.32
Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus. Infect Immun (1981) 1.31
Murine neurotropic retrovirus spongiform polioencephalomyelopathy: acceleration of disease by virus inoculum concentration. Infect Immun (1979) 1.31
Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. J Biol Chem (1994) 1.30
The synthesis and structure of visna virus DNA. Virology (1979) 1.30
Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology (2003) 1.29
The neurobiology of human immunodeficiency virus infections. FASEB J (1988) 1.29
The transmembrane glycoprotein of human immunodeficiency virus type 1 induces syncytium formation in the absence of the receptor binding glycoprotein. J Virol (1992) 1.29
Further studies of a simian virus 40-like virus isolated from human brain. J Virol (1972) 1.28
Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques. AIDS Res Hum Retroviruses (1997) 1.26
Ovine progressive pneumonia: pathologic and virologic studies on the naturally occurring disease. Am J Vet Res (1981) 1.26
Modulating dipoles for structure-function correlations in the gramicidin A channel. Biochemistry (1999) 1.25
Antigenic variation in lentiviral diseases. Annu Rev Immunol (1988) 1.23
Basolateral expression of a chimeric protein in which the transmembrane and cytoplasmic domains of vesicular stomatitis virus G protein have been replaced by those of the influenza virus hemagglutinin. J Biol Chem (1987) 1.23
Cytoplasmic retention of HIV-1 regulatory protein Vpr by protein-protein interaction with a novel human cytoplasmic protein VprBP. Gene (2001) 1.22
Sequence homology between cloned caprine arthritis encephalitis virus and visna virus, two neurotropic lentiviruses. J Virol (1986) 1.22
A new influenza virus infection in turkeys. I. Isolation and characterization of virus 6213. Can Vet J (1968) 1.22
Nonpolarized expression of a secreted murine leukemia virus glycoprotein in polarized epithelial cells. Cell (1986) 1.21
Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB). J Virol (1988) 1.21
Analysis of Borna disease virus-specific RNAs in infected cells and tissues. J Gen Virol (1991) 1.19
Infection with Borna disease virus: molecular and immunobiological characterization of the agent. Clin Infect Dis (1992) 1.19
Biochemical characterization of the virus causing leukoencephalitis and arthritis in goats. J Gen Virol (1980) 1.15
Human immunodeficiency virus infection in microglia: correlation between cells infected in the brain and cells cultured from infectious brain tissue. Ann Neurol (1992) 1.14
Genomic changes associated with antigenic variation of visna virus. II. Common nucleotide sequence changes detected in variants from independent isolations. J Mol Biol (1982) 1.13
Neutralizing antibodies administered before, but not after, virulent SHIV prevent infection in macaques. AIDS Res Hum Retroviruses (1998) 1.13
Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques. Virology (1999) 1.13